Vinva Investment Management’s Biogen BIIB Stock Holding History

Vinva Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Buy	6,056 +4,696	+345%	+$898K	0.01%	322
2026 Q1	$255K	Buy	+1,360	New	+$251K	﹤0.01%	424
2025 Q4	–	Sell	-38,704	Closed	-$5.36M	–	406
2025 Q3	$5.36M	Sell	38,704 -20,158	-34%	-$2.72M	0.1%	177
2025 Q2	$7.42M	Buy	+58,862	New	+$7.33M	0.19%	132
2025 Q1	–	Sell	-1,874	Closed	-$281K	–	386
2024 Q4	$281K	Buy	+1,874	New	+$316K	0.01%	386
2023 Q4	–	Sell	-1,997	Closed	-$515K	–	394
2023 Q3	$515K	Sell	1,997 -2,817	-59%	-$753K	0.05%	294
2023 Q2	$1.36M	Sell	4,814 -56	-1%	-$16.7K	0.12%	192
2023 Q1	$1.34M	Buy	+4,870	New	+$1.35M	0.11%	208

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vinva Investment Management's BIIB Position: Q2 2026 in Review

Vinva Investment Management increased its Biogen (BIIB) stake by 345% in Q2 2026, buying an estimated $898K and bringing the position to 6,056 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #322.

Vinva Investment Management first reported a position in BIIB in Q1 2023 and has held it in 8 quarters since. The position peaked at $7.42M in Q2 2025. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Vinva Investment Management held 6,056 shares of Biogen worth $1.31M as of Q2 2026.
Vinva Investment Management bought 4,696 Biogen shares in Q2 2026, an estimated $898K.
Biogen made up 0.01% of Vinva Investment Management's portfolio in Q2 2026, its #322 holding.
Vinva Investment Management first reported a position in Biogen in Q1 2023 and has held it in 8 quarters since.
Vinva Investment Management's Biogen position peaked at $7.42M in Q2 2025.
1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.